Back to School: How biopharma can reboot drug development. Access exclusive analysis here

AIT-082: Cognitive function have completed dosing in the Canadian Phase I/II trial

NeoTherapeutics Inc. (NEOT), Irvine, Calif.

Read the full 59 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE